Section Arrow
AXSM.NASDAQ
- Axsome Therapeutics
Quotes are at least 15-min delayed:2025/07/20 21:04 EDT
Regular Hours
Last
 111.7
-0.54 (-0.48%)
Day High 
113.66 
Prev. Close
112.24 
1-M High
114.6642 
Volume 
453.65K 
Bid
111.7
Ask
113.2
Day Low
111.1988 
Open
113.06 
1-M Low
99.75 
Market Cap 
5.53B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 109.94 
20-SMA 106.49 
50-SMA 106.85 
52-W High 139.1299 
52-W Low 72.21 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.77/1.50
Enterprise Value
5.72B
Balance Sheet
Book Value Per Share
1.08
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
385.69M
Operating Revenue Per Share
4.54
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
NCNANuCana plc0.0477+0.0009+1.92%-- 
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Quotes are at least 15-min delayed:2025/07/20 21:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.